Dr. Serafini is a partner in the Intellectual Property Group of Fenwick & West LLP, a law firm specializing in technology and life sciences. Dr. Serafini is resident in the Seattle office, and his practice focuses on strategic and comprehensive intellectual property counseling and management to biotechnology, biopharmaceutical and other life sciences clients, to help them obtain, protect and enforce their intellectual property rights, especially in the areas of immunology, molecular biology, molecular genetics, genomics, proteomics and protein chemistry, pharmaceuticals, medical therapeutics, nanotechnology, cleantech and medical diagnostics.
Dr. Serafini’s practice involves preparing and prosecuting U.S. and international patents; performing due diligence and freedom to operate analyses associated with mergers and acquisitions, venture capital and other private and public financings; drafting opinions on patentability, non-infringement and patent validity; product development counseling; contesting interferences, oppositions and arbitrations; and supporting technology litigation.
Dr. Serafini works closely with the venture capital community to help build life sciences start-up companies into industry market leaders. He also partners with public and private universities and research institutions to help safeguard, leverage and bring to market their technology assets and innovations as well as facilitate the technology transfer of these assets and innovations to foster further developments to benefit the public.
Dr. Serafini received his J.D. from the University of California, Hastings College of the Law in 1998. Prior to law school, he earned a Ph.D. in immunology from the Stanford University School of Medicine in 1994 and his B.S., with honors, in biochemistry from the Case Institute of Technology of Case Western Reserve University in 1986.
